Prot #EZH-202: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/7/15 → 12/7/21

Funding

  • Medpace, Inc. (Prot #EZH-202)
  • Epizyme, Inc. (Prot #EZH-202)
View all
View less